Access to essential drugs in poor countries – A lost battle?

by Pécoul, B. et al. JAMA, January 1999, 281(4).

Summary: This article focuses on the problems of access to quality drugs for the treatment of diseases that predominantly affect the developing world: (1) poor-quality and counterfeit drugs; (2) lack of availability of essential drugs due to fluctuating production or prohibitive cost; (3) need to develop field-based drug research to determine optimum utilization and remotivate research and development for new drugs for the developing world; and (4) potential consequences of recent World Trade Organization agreements on the availability of old and new drugs.

Click here to download the full article [PDF]